ACW R&D Rebate Received Totalling $1.22 Million 15/11/17 PRICE SENSITIVE download Created with Sketch. 126.71KB Share ACW Amgen Pioneer to Join Actinogen Board 02/11/17 download Created with Sketch. 143.43KB Share ACW Quarterly Update & Appendix 4C 30/10/17 PRICE SENSITIVE download Created with Sketch. 267.24KB Share ACW Annual Report to Shareholders 23/10/17 download Created with Sketch. 1.38MB Share ACW Notice of Special General Meeting & Proxy Form 23/10/17 download Created with Sketch. 298.95KB Share ACW Notice of Annual General Meeting/Proxy Form 23/10/17 download Created with Sketch. 446.14KB Share ACW Actinogen to be showcased at key conferences 17/10/17 download Created with Sketch. 1.08MB Share ACW Investor Newsletter 12/10/17 download Created with Sketch. 122.09KB Share ACW Final Major Market Patent Granted for Xanamem 11/10/17 PRICE SENSITIVE download Created with Sketch. 132.68KB Share ACW Lapse of Unlisted Options 22/09/17 download Created with Sketch. 92.78KB Share ACW First Patient Completes Landmark Alzheimer's Disease Trial 07/09/17 PRICE SENSITIVE download Created with Sketch. 159.41KB Share ACW Appendix 4G 18/08/17 download Created with Sketch. 151.63KB Share ACW Appendix 4E & Financial Statements 18/08/17 PRICE SENSITIVE download Created with Sketch. 1.39MB Share ACW First UK patient treated in ground-breaking clinical trial 16/08/17 PRICE SENSITIVE download Created with Sketch. 167.64KB Share ACW Final Director's Interest Notice 14/08/17 download Created with Sketch. 26.61KB Share ACW Resignation of Director 14/08/17 download Created with Sketch. 122.09KB Share ACW June Quarterly Update 26/07/17 PRICE SENSITIVE download Created with Sketch. 256.59KB Share ACW Actinogen Presenting at Bioshares Biotech 2017 Summit 19/07/17 download Created with Sketch. 1.16MB Share ACW Appendix 3B-Issue of Employee Options 12/07/17 download Created with Sketch. 150.3KB Share ACW Change of Director's Interest Notice 07/07/17 download Created with Sketch. 24.11KB Share ACW Lapse of Unlisted Options 03/07/17 download Created with Sketch. 92.85KB Share ACW First US Patients Treated in Landmark Alzheimer's Trial 22/06/17 PRICE SENSITIVE download Created with Sketch. 141.76KB Share ACW Actinogen Medical Attending BIO 2017 19/06/17 download Created with Sketch. 1.24MB Share ACW First UK Site Goes Live in Global Alzheimer's Clinical Trial 01/06/17 PRICE SENSITIVE download Created with Sketch. 136.04KB Share ACW First Patient Treated in Landmark Alzheimer's Clinical Trial 16/05/17 PRICE SENSITIVE download Created with Sketch. 143.19KB Share ACW Section 708A Notice 09/05/17 download Created with Sketch. 97.98KB Share ACW Appendix 3B-Exercise of Options 09/05/17 download Created with Sketch. 149.66KB Share ACW Becoming a substantial holder 26/04/17 download Created with Sketch. 125.3KB Share ACW Section 708A Notice 26/04/17 download Created with Sketch. 97.46KB Share ACW Appendix 3B-Exercise of Options 26/04/17 download Created with Sketch. 149.6KB Share ACW March Quarterly Update 26/04/17 PRICE SENSITIVE download Created with Sketch. 262.94KB Share ACW Change of Director's Interest Notice 29/03/17 download Created with Sketch. 24.32KB Share ACW Latest Investor Presentation 27/03/17 download Created with Sketch. 1.17MB Share ACW Change of Director's Interest Notice 27/03/17 download Created with Sketch. 23.23KB Share ACW Appendix 3B 27/03/17 download Created with Sketch. 149.96KB Share ACW Quarterly Investor Newsletter 16/03/17 download Created with Sketch. 100.83KB Share ACW TGA Regulatory Approval for Alzheimer's Phase II Trial 08/03/17 PRICE SENSITIVE download Created with Sketch. 114.8KB Share ACW Initial Director's Interest Notice 01/03/17 download Created with Sketch. 64.01KB Share ACW Actinogen Medical Appoints Dr Geoff Brooke as Chairman 01/03/17 download Created with Sketch. 114.89KB Share ACW Actinogen Medical Financial Results 27/02/17 PRICE SENSITIVE download Created with Sketch. 718.2KB Share ACW UK Regulatory Approval for Alzheimer's Clinical Trial-XanADu 10/02/17 PRICE SENSITIVE download Created with Sketch. 134.23KB Share ACW Xanamem Research Published in Prestigious Medical Journal 09/02/17 PRICE SENSITIVE download Created with Sketch. 158.45KB Share ACW Issue of Employee & Advisor Options 06/02/17 download Created with Sketch. 326.83KB Share ACW Appendix 4C - quarterly 23/01/17 PRICE SENSITIVE download Created with Sketch. 48.42KB Share ACW Ceasing to be a substantial holder 09/01/17 download Created with Sketch. 56.07KB Share ACW FDA Approval to Commence Alzheimer's Disease Clinical Trial 03/01/17 PRICE SENSITIVE download Created with Sketch. 116.67KB Share ACW Lapse of Unlisted Options 03/01/17 download Created with Sketch. 97.74KB Share ACW Trading Halt 30/12/16 PRICE SENSITIVE download Created with Sketch. 202.78KB Share ACW Significant Advance in Development of Alzheimer's Drug 19/12/16 PRICE SENSITIVE download Created with Sketch. 157.04KB Share ACW Xanamem Research Presented at CTAD 06/12/16 download Created with Sketch. 131.74KB Share ACW Appendix 3Z 30/11/16 download Created with Sketch. 166.86KB Share ACW Resignation of Director 30/11/16 download Created with Sketch. 103.58KB Share ACW Results of Annual General Meeting 30/11/16 download Created with Sketch. 198.16KB Share ACW CEO's Presentation to AGM 30/11/16 download Created with Sketch. 1.72MB Share ACW Chairman's AGM Address 30/11/16 download Created with Sketch. 139.65KB Share ACW Appendix 4C - quarterly-ACW.AX 26/10/16 PRICE SENSITIVE download Created with Sketch. 48.32KB Share ACW Annual Report to Shareholders-ACW.AX 24/10/16 download Created with Sketch. 2.24MB Share ACW Notice of Annual General Meeting/Proxy Form-ACW.AX 24/10/16 download Created with Sketch. 445.52KB Share ACW Ceasing to be a substantial holder-ACW.AX 14/10/16 download Created with Sketch. 1.17MB Share ACW Ceasing to be a substantial holder-ACW.AX 06/10/16 download Created with Sketch. 360.86KB Share ACW Changes to the Actinogen Medical Board-ACW.AX 05/10/16 download Created with Sketch. 106.89KB Share ACW FDA Feedback on Xanamem Alzheimer's Trail-ACW.AX 29/09/16 PRICE SENSITIVE download Created with Sketch. 105.12KB Share ACW R&D Tax Rebate-ACW.AX 05/09/16 PRICE SENSITIVE download Created with Sketch. 104.59KB Share ACW Investor Update-August 2016-ACW.AX 01/09/16 download Created with Sketch. 800.16KB Share ACW Appendix 4E & Financial Statements-ACW.AX 31/08/16 PRICE SENSITIVE download Created with Sketch. 2.55MB Share ACW Appendix 4G-ACW.AX 31/08/16 download Created with Sketch. 87.72KB Share ACW Ceasing to be a substantial holder-ACW.AX 24/08/16 download Created with Sketch. 1012.35KB Share ACW Less Than Marketable Parcel Sale-ACW.AX 17/08/16 download Created with Sketch. 225.19KB Share ACW Landmark Research on Excess Cortisol & Alzheimer's Disease-ACW.AX 28/07/16 PRICE SENSITIVE download Created with Sketch. 202.76KB Share ACW US Patent Granted-Further Extends Xanamem Protection-ACW.AX 20/07/16 PRICE SENSITIVE download Created with Sketch. 120.15KB Share ACW US Roadshow Investor Presentation-ACW.AX 15/07/16 download Created with Sketch. 2.62MB Share ACW Appendix 4C - quarterly-ACW.AX 15/07/16 PRICE SENSITIVE download Created with Sketch. 83.2KB Share ACW Issue of Employee Options-ACW.AX 08/07/16 download Created with Sketch. 244.37KB Share ACW Xanamem & AIBL to showcase Cortisol Hypothesis in Alzheimers-ACW.AX 29/06/16 download Created with Sketch. 147.21KB Share ACW US FDA Feedback Enhances Alzheimers Study-ACW.AX 08/06/16 PRICE SENSITIVE download Created with Sketch. 111.02KB Share ACW Change of Share Register Notification-ACW.AX 20/05/16 download Created with Sketch. 96.99KB Share ACW Section 708A Notice-ACW.AX 06/05/16 download Created with Sketch. 88KB Share ACW Appendix 3B-ACW.AX 06/05/16 download Created with Sketch. 146.29KB Share ACW BioEquity & Ausbiotech Asia Investor Presentation May 2016-ACW.AX 03/05/16 download Created with Sketch. 3.39MB Share ACW Appendix 4C - quarterly-ACW.AX 15/04/16 PRICE SENSITIVE download Created with Sketch. 83.08KB Share ACW Launch of XanADu Phase II Clinical Trial 22/03/16 PRICE SENSITIVE download Created with Sketch. 140.86KB Share ACW Xanamem Cortisol Hypothesis-Investor Presentation 10/03/16 download Created with Sketch. 2.06MB Share ACW Appendix 4D & Half Year Report 19/02/16 PRICE SENSITIVE download Created with Sketch. 611.69KB Share ACW R&D Rebate 09/02/16 PRICE SENSITIVE download Created with Sketch. 95.27KB Share ACW Appendix 4C - quarterly 27/01/16 PRICE SENSITIVE download Created with Sketch. 83KB Share ACW Appendix 3Y-Dr Bill Ketelbey 04/01/16 download Created with Sketch. 23.98KB Share ACW Investor Update-December 2015 01/12/15 download Created with Sketch. 1.92MB Share ACW Change of Company Name 17/11/15 download Created with Sketch. 94.24KB Share ACW Results of AGM 12/11/15 download Created with Sketch. 89.8KB Share ACW CEO's AGM Presentation 12/11/15 download Created with Sketch. 1.16MB Share ACW Chairman's AGM Address 12/11/15 download Created with Sketch. 132.76KB Share ACW Release of Securities from Voluntary Escrow 06/11/15 download Created with Sketch. 71.57KB Share ACW Appendix 4C - quarterly 15/10/15 PRICE SENSITIVE download Created with Sketch. 82.27KB Share ACW Annual Report to shareholders 07/10/15 download Created with Sketch. 1011.93KB Share ACW Notice of Annual General Meeting/Proxy Form 07/10/15 download Created with Sketch. 591.18KB Share ACW Understanding Alzheimer's Symposium 07/10/15 download Created with Sketch. 129.78KB Share ACW Expiry of Listed Options 30/09/15 download Created with Sketch. 74.19KB Share ACW Positive Trial Results for Alzheimers Drug Xanamem 29/09/15 PRICE SENSITIVE download Created with Sketch. 153.84KB Share ACW Trading Halt 28/09/15 PRICE SENSITIVE download Created with Sketch. 367.84KB Share ACW Expiry of Listed Options & Waiver of LIsting Rule 6.24 31/08/15 download Created with Sketch. 115.15KB Share
(20min delay)
